These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22650360

  • 1. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model.
    Saracino S, Canuto RA, Maggiora M, Oraldi M, Scoletta M, Ciuffreda L, Vandone AM, Carossa S, Mozzati M, Muzio G.
    J Oral Pathol Med; 2012 Nov; 41(10):788-92. PubMed ID: 22650360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Zoledronic acid decreases gene expression of vascular endothelial growth factor and basic fibroblast growth factor by human epithelial cells.
    Basso FG, Turrioni AP, Hebling J, de Souza Costa CA.
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):971-3. PubMed ID: 23773293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
    Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.
    J Clin Oncol; 2005 Dec 01; 23(34):8580-7. PubMed ID: 16314620
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R, Sourla A, Lembessis P, Koutsilieris M.
    Anticancer Res; 2006 Dec 01; 26(1A):283-91. PubMed ID: 16475708
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
    García Sáenz JA, López Tarruella S, García Paredes B, Rodríguez Lajusticia L, Villalobos L, Díaz Rubio E.
    Med Oral Patol Oral Cir Bucal; 2007 Sep 01; 12(5):E351-6. PubMed ID: 17767097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro.
    Kadow-Romacker A, Greiner S, Schmidmaier G, Wildemann B.
    J Biomater Appl; 2013 Jan 01; 27(5):577-85. PubMed ID: 21862509
    [Abstract] [Full Text] [Related]

  • 18. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
    Greiner S, Kadow-Romacker A, Schmidmaier G, Wildemann B.
    J Biomed Mater Res A; 2009 Oct 01; 91(1):288-95. PubMed ID: 18980195
    [Abstract] [Full Text] [Related]

  • 19. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
    Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ.
    J Oral Pathol Med; 2014 Oct 01; 43(9):711-21. PubMed ID: 24762323
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.